Stockscreener 앱 받기
30.49
3.01%
0.88
전일 마감가:
$29.61
열려 있는:
$29.94
하루 거래량:
944.33K
Relative Volume:
0.67
시가총액:
$1.70B
수익:
$249.12M
순이익/손실:
$-90.19M
주가수익비율:
-17.94
EPS:
-1.7
순현금흐름:
$-88.21M
1주 성능:
+0.63%
1개월 성능:
-5.89%
6개월 성능:
-45.26%
1년 성능:
-59.16%
1일 변동 폭
$29.65
$31.34
1주일 범위
$28.76
$32.05
52주 변동 폭
$27.80
$75.29
Procept Biorobotics Corp Stock (PRCT) Company Profile
명칭
Procept Biorobotics Corp
전화
(650) 232-9832
주소
150 BAYTECH DRIVE, SAN JOSE
PRCT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
30.48 | 1.65B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
107.25 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.24 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
355.73 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.27 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.68 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-12 | 개시 | UBS | Buy |
| 2025-12-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-09-02 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-07-09 | 개시 | Stephens | Overweight |
| 2025-07-07 | 개시 | Oppenheimer | Perform |
| 2024-12-02 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 개시 | Jefferies | Hold |
| 2023-08-11 | 개시 | Piper Sandler | Overweight |
| 2023-05-31 | 개시 | William Blair | Outperform |
| 2022-10-31 | 개시 | BTIG Research | Neutral |
| 2022-10-25 | 개시 | Truist | Buy |
| 2022-09-02 | 개시 | Wells Fargo | Overweight |
| 2022-07-15 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | 개시 | B. Riley Securities | Buy |
| 2021-10-11 | 개시 | BofA Securities | Buy |
| 2021-10-11 | 개시 | Cowen | Outperform |
| 2021-10-11 | 개시 | Goldman | Neutral |
| 2021-10-11 | 개시 | Guggenheim | Buy |
| 2021-10-11 | 개시 | SVB Leerink | Outperform |
모두보기
Procept Biorobotics Corp 주식(PRCT)의 최신 뉴스
PROCEPT BioRobotics to Report Q4 2025 Financial Results and Host Investor Day Event in February 2026 - Quiver Quantitative
Surgery robot firm PROCEPT plans Feb. 25 investor day at Nasdaq HQ - Stock Titan
Did AquaBeam Milestones and Options Activity Just Shift PROCEPT BioRobotics' (PRCT) Investment Narrative? - simplywall.st
A Look At PROCEPT BioRobotics (PRCT) Valuation As Regulatory And Clinical Catalysts Draw Investor Focus - simplywall.st
First Week of March 20th Options Trading For PROCEPT BioRobotics (PRCT) - InteractiveCrypto
Will PROCEPT BioRobotics Corporation benefit from current market trendsBreakout Watch & Expert-Curated Trade Recommendations - bollywoodhelpline.com
Is PROCEPT BioRobotics Corporation stock a buy or sell2025 EndofYear Setup & Long-Term Safe Return Strategies - bollywoodhelpline.com
Promising growth forecasts leading to analysts’ optimism for Procept Biorobotics (PRCT) - MSN
FMR LLC Reduces Stake in PROCEPT BioRobotics Corp by 42.10% - GuruFocus
US Market Wrap: What risks investors should watch in PROCEPT BioRobotics Corporation stock - Bộ Nội Vụ
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Assessing PROCEPT BioRobotics (PRCT) Valuation As Fresh Analyst Downgrade Meets Confident Long-Term Growth Views - simplywall.st
Peregrine Capital Management LLC Purchases Shares of 188,219 PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
Will PROCEPT BioRobotics Corporation stock outperform value stocksJuly 2025 Pullbacks & Real-Time Buy Zone Alerts - Улправда
Procept BioRobotics initiated with a buy at UBS - MSN
PROCEPT BioRobotics (NASDAQ:PRCT) Trading Down 7.1%Here's Why - MarketBeat
Is Wall Street’s Split View On PROCEPT BioRobotics (PRCT) Revealing Aquablation’s True Strategic Position? - simplywall.st
Truist Maintains Buy Rating on Procept BioRobotics (PRCT) Amid MedTech Sector Rotation - Finviz
Will PROCEPT BioRobotics Corporation stock return to pre crisis levels2025 Investor Takeaways & Capital Protection Trading Alerts - Улправда
ISRG Trading 4% Below All-Time High: Should You Buy the Stock Now? - Nasdaq
PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: A 53% Potential Upside in the Surgical Robotics Arena - DirectorsTalk Interviews
PROCEPT BioRobotics Corporation $PRCT Shares Purchased by Chicago Capital LLC - MarketBeat
PROCEPT BioRobotics Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Best Robotics Stocks To ConsiderDecember 26th - MarketBeat
How Investors Are Reacting To PROCEPT BioRobotics (PRCT) UBS Coverage Initiation And 2027 Profitability Outlook - simplywall.st
What Wall Street predicts for PROCEPT BioRobotics Corporation stock priceConsumer Goods Stocks & Free Record-Breaking Gains - Bollywood Helpline
Promising Growth Forecasts Leading to Analysts' Optimism for Procept Biorobotics (PRCT) - Finviz
Promising Growth Forecasts Leading to Analysts’ Optimism for Procept Biorobotics (PRCT) - Yahoo Finance
15 Most Promising Mid-Cap Healthcare Stocks Under $50 - Insider Monkey
Aug EndMonth: What Wall Street predicts for PROCEPT BioRobotics Corporation stock priceJuly 2025 Gainers & AI Driven Stock Movement Reports - Улправда
Transcript : PROCEPT BioRobotics Corporation Presents at Piper Sandler 37th Annual Healthcare Conference, Dec-02-2025 08 - marketscreener.com
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Procept BioRobotics price target lowered to $47 from $50 at Truist - TipRanks
Truist Financial Has Lowered Expectations for PROCEPT BioRobotics (NASDAQ:PRCT) Stock Price - MarketBeat
Truist Financial Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Cuts Target Price to $47 - 富途牛牛
Truist Securities Adjusts Price Target on PROCEPT BioRobotics to $47 From $50, Maintains Buy Rating - marketscreener.com
PROCEPT BioRobotics (PRCT) Stock Analysis: Eyeing a 41% Upside with Robust Revenue Growth - directorstalkinterviews.com
3 Underrated Robotics Stocks Poised for Huge Gains - Investing.com
PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Shareholders Might Be Looking For Exit - 富途牛牛
Squarepoint Ops LLC Decreases Stake in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Downgraded by Wall Street Zen to Sell - MarketBeat
PROCEPT BioRobotics Corporation $PRCT Shares Bought by Eventide Asset Management LLC - MarketBeat
Bellevue Group AG Acquires 74,355 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
UBS Initiates Coverage of PROCEPT BioRobotics (PRCT) with Buy Recommendation - Nasdaq
UBS initiates Procept BioRobotics stock with Buy rating on utilization growth - Investing.com Australia
PRCT FinancialsIncome Statement - Quiver Quantitative
Procept BioRobotics initiated with a Buy at UBS - TipRanks
Procept Biorobotics Corp (PRCT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.90%
0.36%
자본화:
|
볼륨(24시간):